Impact Through Grant Funding

Traditionally, early-career scientists and those with more novel approaches to their research face considerable difficulty securing funding for their work. This is partly due to the higher-risk nature of their work, while both established scientists and those pursuing proven methods of study are considered less risky to fund. New Vision Research alters the current landscape of funding by intentionally connecting and supporting early-career researchers with innovative ideas through CCAD.

Read More »
A Way Forward

A Way Forward is a four-part series dedicated to sharing these challenges with the CCAD community, along with ways to help address them and contribute to their resolution.

We believe diversity in ideas leads to better medical research, and to achieve this, it is important to identify and address individual, community and institutional challenges scientists face that hold us back as a community. The first piece is written by PhD student Melise Edwards. To read her article click on the button below.

Read More »
New Vision Research Focus: Thomas Kukar

I am excited to share a brief update on my research since attending the Charleston Conferences on Alzheimer’s Disease (CCAD) in 2014. It is hard to capture the entire roller coaster ride of starting a research lab, so I will share a few highlights. Currently, I am an Associate Professor with appointments in the Department of Pharmacology & Chemical Biology and Neurology in the School of Medicine at Emory University…

Read More »
Peter Davies, Ph.D.

Peter Davies, PhD. (1948 –  2020) It is not the most distinguished achievements that men’s virtues or vices may be best discovered; but very often an action of small note.

Read More »
Scroll to Top